Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting
Simultaneous detection of proteins and RNA markers across 23 different tissue samples demonstrate robust and…
Simultaneous detection of proteins and RNA markers across 23 different tissue samples demonstrate robust and…
Simultaneous detection of proteins and RNA markers across 23 different tissue samples demonstrate robust and…
NEEDHAM, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical…
NEEDHAM, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical…
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…
WALTHAM, Mass. and BOULDER, Colo., Feb. 01, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
WALTHAM, Mass. and BOULDER, Colo., Feb. 01, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
MALVERN, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
MALVERN, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
CALGARY, Alberta, Feb. 01, 2023 (GLOBE NEWSWIRE) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical…
CALGARY, Alberta, Feb. 01, 2023 (GLOBE NEWSWIRE) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical…
Company plans to report interim data for the combination of UpRi with carboplatin in the second…
Company plans to report interim data for the combination of UpRi with carboplatin in the second…
MELBOURNE, Australia, Feb. 01, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”),…
MELBOURNE, Australia, Feb. 01, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”),…
TORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia…
TORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia…